Skip to main content
. 2018 May;17(5):416–422. doi: 10.1016/S1474-4422(18)30054-1

Figure 1.

Figure 1

Patients progressing from each stage of amyotrophic lateral sclerosis with riluzole or placebo

(A) Treatment with 100 mg riluzole per day significantly prolonged time in stage 4 compared with placebo (p=0·037). (B) Treatment with all doses did not prolong time in stage 2 compared with placebo (p=0·827). (C) Treatment with all doses did not prolong time in stage 3 compared with placebo (p=0·882). HR=hazard ratio.